Your browser doesn't support javascript.
loading
Clostridium difficile infection in pediatric patients (Review).
Dop, Dalia; Marcu, Iulia Rahela; Padureanu, Vlad; Caragea, Daniel Cosmin; Padureanu, Rodica; Niculescu, Stefan-Adrian; Niculescu, Carmen Elena.
Afiliación
  • Dop D; Department of Pediatrics, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania.
  • Marcu IR; Department of Physical and Rehabilitation Medicine, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania.
  • Padureanu V; Department of Internal Medicine, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania.
  • Caragea DC; Department of Nephrology, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania.
  • Padureanu R; Department of Internal Medicine, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania.
  • Niculescu SA; Department of Orthopedics, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania.
  • Niculescu CE; Department of Pediatrics, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania.
Biomed Rep ; 20(2): 18, 2024 Feb.
Article en En | MEDLINE | ID: mdl-38169799
ABSTRACT
Clostridium difficile (C. difficile) infection (CDI) is the most common cause of healthcare-associated diarrhea and among adults, the worldwide incidence rate of the infection is increasing. There is a small amount of data in the literature for pediatric patients, but most indicate an increasing trend. C. difficile is a constituent of the normal microbiota; however, under specific conditions that cause a disruption of the normal bacterial flora, colonization of C. difficile and the released toxins that cause inflammation and mucosal damage occurs. Risk factors for CDI at any age include hospitalization, exposure to antibiotics, administration of proton pump inhibitors, invasive mechanical ventilation, immunosuppression and presence of associated comorbidities. Clinical manifestations range from asymptomatic colonization to fulminant disease characterized by toxic megacolon, intestinal perforation and, rarely, death. The aim of the present review was to outline the features of CDI in pediatric patients.
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Risk_factors_studies Idioma: En Revista: Biomed Rep Año: 2024 Tipo del documento: Article País de afiliación: Rumanía

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Risk_factors_studies Idioma: En Revista: Biomed Rep Año: 2024 Tipo del documento: Article País de afiliación: Rumanía